Miskowiak Kamilla, O'Sullivan Ursula, Harmer Catherine J
Department of Experimental Psychology, University of Oxford, Oxford OX1 3UD, United Kingdom.
J Neurosci. 2007 Mar 14;27(11):2788-92. doi: 10.1523/JNEUROSCI.5013-06.2007.
Although erythropoietin (Epo) is best known for its effects on erythropoiesis, recent evidence suggests that it also has neurotrophic and neuroprotective properties in animal models of hippocampal function. Such an action in humans would make it an intriguing novel compound for the treatment of neurological and psychiatric disorders. The current study therefore aimed to explore the effects of Epo on neural and behavioral measures of hippocampal function in humans using a functional magnetic resonance imaging paradigm. Volunteers were randomized to receive intravenous injection of Epo (40,000 IU) or saline in a between-subjects, double-blind, randomized design. Neural response during picture encoding and retrieval was tested 1 week later. Epo increased hippocampus response during picture retrieval (n = 11) compared with placebo (n = 12; p = 0.04) independent of changes in hematocrit. This is consistent with upregulation of hippocampal BDNF and neurotrophic actions found in animals and highlights Epo as a promising candidate for treatment of psychiatric disorders.
尽管促红细胞生成素(Epo)因其对红细胞生成的作用而最为人所知,但最近的证据表明,在海马功能的动物模型中,它还具有神经营养和神经保护特性。这种作用在人类身上会使其成为一种用于治疗神经和精神疾病的有趣的新型化合物。因此,本研究旨在使用功能磁共振成像范式,探索Epo对人类海马功能的神经和行为指标的影响。志愿者被随机分配,以受试者间、双盲、随机设计接受静脉注射Epo(40,000国际单位)或生理盐水。1周后测试图片编码和检索过程中的神经反应。与安慰剂组(n = 12;p = 0.04)相比,Epo组(n = 11)在图片检索过程中海马反应增强,且与血细胞比容的变化无关。这与在动物中发现的海马脑源性神经营养因子上调和神经营养作用一致,并突出了Epo作为治疗精神疾病的有前景的候选药物。